Patient Advocacy - Is There a Danger of FDA Become More Hawkish?

There's been a great mobilization of advocacy groups as you look at interactions with the FDA. I think there's some cases where, you know, that effectively has gone full circle and not necessarily been as positive ultimately as one would have hoped. You talk about the potential for the FDA becoming more hawkish. Is there the danger that we may see that actually that hawkishness move over into that part of the communication with the FDA?